Skip to main content
SpringerLink
Log in

Interleukin-2/ipilimumab/pembrolizumab

Various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Clark JI, et al. Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: A case report. Journal for ImmunoTherapy of Cancer 6: 53, No. 1, 14 Jun 2018. Available from: URL: http://doi.org/10.1186/s40425-018-0370-6 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Interleukin-2/ipilimumab/pembrolizumab. Reactions Weekly 1710, 177 (2018). https://doi.org/10.1007/s40278-018-48850-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-48850-x

Search

Navigation